Trial intelligence / Profile preview

Melatonin for Cardiac Morbidity in Aortic Aneurysm Repair

NCT00315926Phase 3Completed

Sponsor
Gentofte Hospital
Start
Jan 2007
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin in Myocardial injury, sponsored by Gentofte Hospital. Started Jan 2007; status: completed.

02

Drugs

melatonin
03

Conditions

Myocardial injury

Beyond the preview

Go deeper on NCT00315926.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00315926.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call